Search

Your search keyword '"Krueger, James G."' showing total 1,551 results

Search Constraints

Start Over You searched for: Author "Krueger, James G." Remove constraint Author: "Krueger, James G."
1,551 results on '"Krueger, James G."'

Search Results

351. Hepatocyte Growth Factor Has Unique Functions in Keratinocytes that Differ from those of IL-17A and TNF and May Contribute to Inflammatory Pathways in Hidradenitis Suppurativa

352. Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1

353. Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis.

354. The aging skin microenvironment dictates stem cell behavior.

355. Reply

358. Atopic dermatitis in Chinese patients shows TH2/TH17 skewing with psoriasiform features

359. The human CIB1–EVER1–EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses

360. Serum from Asian patients with atopic dermatitis is characterized by TH2/TH22 activation, which is highly correlated with nonlesional skin measures

361. Early-onset pediatric atopic dermatitis is characterized by TH2/TH17/TH22-centered inflammation and lipid alterations

362. Author Correction: The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins

363. Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial

366. Reduction of Inflammatory and Cardiovascular Proteins in the Blood of Patients with Psoriasis: Differential Responses between Tofacitinib and Etanercept after 4 Weeks of Treatment

368. The Rockefeller University Clinical Scholars (KL2) program 2006–2016

370. Response to Hjuler et al.

373. Quantifying the natural variation in lesion counts over time in untreated hidradenitis suppurativa: Implications for outcome measures and trial design

374. A Preliminary 18F-FDG-PET/MRI Study Shows Increased Vascular Inflammation in Moderate-to-Severe Atopic Dermatitis

378. Line scanning, stage scanning confocal microscope (LSSSCM)

379. Alterations in B-cell subsets in pediatric patients with early atopic dermatitis

382. IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment

383. Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10

387. Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis

390. Aberrant connective tissue differentiation towards cartilage and bone underlies human keloids in African Americans

391. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism

392. Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling

396. Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway

397. An IL-17–dominant immune profile is shared across the major orphan forms of ichthyosis

398. Digital imaging biomarkers feed machine learning for melanoma screening

399. Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin

Catalog

Books, media, physical & digital resources